RG
Redmile Group Portfolio holdings
AUM
$940M
This Quarter Return
+6.62%
1 Year Return
+75.78%
3 Year Return
+543.67%
5 Year Return
+585.96%
10 Year Return
+6,653.82%
AUM
$6.76B
AUM Growth
+$6.76B
(-4.8%)
Cap. Flow
-$348M
Cap. Flow
% of AUM
-5.15%
Top 10 Holdings %
Top 10 Hldgs %
43.88%
Holding
93
New
7
Increased
14
Reduced
55
Closed
7
Top Buys
| 1 |
VERV
Verve Therapeutics
VERV
|
$117M |
| 2 |
The Beauty Health Co
SKIN
|
$73.4M |
| 3 |
ZY
Zymergen Inc. Common Stock
ZY
|
$60.9M |
| 4 |
ONEM
1Life Healthcare, Inc. Common Stock
ONEM
|
$36.5M |
| 5 |
Lifestance Health
LFST
|
$35M |
Top Sells
| 1 |
Medtronic
MDT
|
$116M |
| 2 |
Zentalis Pharmaceuticals
ZNTL
|
$95.5M |
| 3 |
GNMK
GenMark Diagnostics, Inc
GNMK
|
$85.8M |
| 4 |
Beam Therapeutics
BEAM
|
$61.8M |
| 5 |
Biogen
BIIB
|
$45.6M |
Sector Composition
| 1 | Healthcare | 95.41% |
| 2 | Consumer Staples | 1.58% |
| 3 | Financials | 0.69% |
| 4 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CTLT
51
DELISTED
CATALENT, INC.
CTLT
| $33.5M | 0.5% |
310,111
-1,508
| -0.5% | -$163K |
|
52
Zymeworks
ZYME
$1.07B
| $32.6M | 0.48% |
939,697
-46,003
| -5% | -$1.6M |
|
|
AMED
53
DELISTED
Amedisys
AMED
| $32.4M | 0.48% |
132,458
-522
| -0.4% | -$128K |
|
|
KLRS
54
Kalaris Therapeutics, Inc. Common Stock
KLRS
$85.5M
| $31.3M | 0.46% |
1,584,093
-359,494
| -18% | -$7.1M |
|
55
LAVA Therapeutics
LVTX
$41.3M
| $30.6M | 0.45% |
2,816,196
-8,213
| -0.3% | -$89.4K |
|
56
Avita Medical
RCEL
$116M
| $29M | 0.43% |
1,411,117
-257,210
| -15% | -$5.28M |
|
57
Ardelyx
ARDX
$1.57B
| $28.2M | 0.42% |
3,714,100
+200,000
| +6% | +$1.52M |
|
58
Bioventus
BVS
$471M
| $26.2M | 0.39% |
1,486,956
-13,044
| -0.9% | -$230K |
|
|
59
Zentalis Pharmaceuticals
ZNTL
$123M
| $22.6M | 0.34% |
425,480
-1,795,564
| -81% | -$95.5M |
|
60
Immatics
IMTX
$662M
| $22.5M | 0.33% |
1,941,892
-140,922
| -7% | -$1.64M |
|
|
PPD
61
DELISTED
PPD, Inc. Common Stock
PPD
| $21.5M | 0.32% |
466,471
-354,621
| -43% | -$16.3M |
|
|
BCEL
62
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $21M | 0.31% |
2,460,268
-30,300
| -1% | -$258K |
|
63
Quantum-Si Incorporated
QSI
$217M
| $20.8M | 0.31% |
+1,700,000
| New | +$20.8M |
|
|
ACHL
64
DELISTED
Achilles Therapeutics plc American Depositary Shares
ACHL
| $20.4M | 0.3% |
2,088,089
| – | – |
|
|
GRTS
65
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $20.3M | 0.3% |
2,226,206
-221,952
| -9% | -$2.03M |
|
|
ITMR
66
DELISTED
Itamar Medical Ltd. American Depository Shares
ITMR
| $20.1M | 0.3% |
854,900
-64,000
| -7% | -$1.51M |
|
67
Senti Biosciences
SNTI
$37.9M
| $20M | 0.3% |
+2,012,900
| New | +$20M |
|
68
InnovAge Holding
INNV
$509M
| $18M | 0.27% |
843,578
-6,422
| -0.8% | -$137K |
|
69
Stereotaxis
STXS
$246M
| $17.9M | 0.26% |
1,855,504
-1,386,099
| -43% | -$13.4M |
|
70
Alpha Teknova
TKNO
$227M
| $17.2M | 0.25% |
+725,000
| New | +$17.2M |
|
|
HOOK
71
DELISTED
HOOKIPA Pharma
HOOK
| $17M | 0.25% |
1,856,205
+13,303
| +0.7% | +$122K |
|
72
Quanterix
QTRX
$202M
| $14.1M | 0.21% |
240,933
-59,067
| -20% | -$3.46M |
|
|
PROF
73
Profound Medical
PROF
$131M
| $12.9M | 0.19% |
787,346
-58,328
| -7% | -$954K |
|
74
Treace Medical Concepts
TMCI
$458M
| $10.1M | 0.15% |
+323,765
| New | +$10.1M |
|
75
Cytosorbents Corp
CTSO
$61.5M
| $9.85M | 0.15% |
1,304,369
-823,262
| -39% | -$6.22M |
|